Form 990 for tax year 2024

Totals

Total revenue

$2,520,856

Total expenses

$2,416,903

Contributions and grants received

$743,500

Grants paid

$275,500

Program service revenue

$1,595,469

Investment income

$162,637

Other revenue

$19,250

Total assets, end of year

$8,087,312

Total liabilities, end of year

$1,066,504

Net assets or fund balances, end of year

$7,020,808

Program services expenses (Part IX)

$1,503,914

Management and general expenses

$912,989

Fundraising expenses

$0

Program service expenses (Part III)

$1,503,914

Program services were 62.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2024

• ANNUAL MEETING OF THE AMERICAN GLAUCOMA SOCIETY - THE AGS HOLDS AN ANNUAL SCIENTIFIC MEETING THAT DRAWS ON AVERAGE OF 950 GLAUCOMA PROFESSIONALS.

  Expenses $873,865 · Revenue $923,395

• RESEARCH GRANTS - AGS PROGRAMS INCLUDE AWARDING RESEARCH GRANTS TO YOUNG AND MID-CAREER PHYSICIAN SCIENTISTS; ON AVERAGE FOUR GRANTS ARE AWARDED. THE AGS ALSO HAS A MENTORING PROGRAM FOR THE ADVANCEMENT OF PHYSICIAN SCIENTISTS. THIS PROGRAM IS FUNDED BY A CORPORATE SUPPORTER OR A FOUNDATION AND ITS MISSION IS TO PROVIDE FINANCIAL AID TO YOUNG GLAUCOMATOLOGISTS TO OVERCOME BARRIERS IN THEIR EARLY CAREER PATH; SIX TO TEN AWARDS ARE GRANTED ANNUALLY DEPENDING ON FUNDING.

  Expenses $200,000 · Grants $200,000

• OPHTHALMOLOGY GLAUCOMA - OPHTHALMOLOGY GLAUCOMA PROVIDES A STIMULATING FORUM FOR DISCUSSION OF CLINICAL, SCIENTIFIC, AND SOCIOECONOMIC ISSUES OF GREATEST CONCERN TO CLINICIANS WHO CARE FOR GLAUCOMA PATIENTS. EACH ISSUE PRESENTS ORIGINAL ARTICLES ON NEW APPROACHES TO DIAGNOSIS, INNOVATIONS IN PHARMACOLOGICAL THERAPY AND SURGICAL TECHNIQUE, AND BASIC SCIENCE ADVANCES THAT IMPACT CLINICAL PRACTICE.

  Expenses $120,453

• OTHER PROGRAM SERVICES INCLUDE GRANTS TO OUTSIDE ORGANIZATIONS WORKING WITH GLAUCOMA AND ISSUES OF THE EYE, MEMBERSHIP DUES ADMINISTRATION, AS WELL AS MISCELLANEOUS BOARD APPROVED SPECIAL PROJECTS.

  Expenses $309,596 · Grants $75,500 · Revenue $672,074

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

• DUKE UNIVERSITY

  $100,000

  GLAUCOMA RESEARCH

• REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO

  $50,000

  GLAUCOMA RESEARCH

• UNIVERSITY OF MIAMI

  $50,000

  GLAUCOMA RESEARCH

• AMERICAN ACADEMY OF OPHTHALMOLOGY

  $30,000

  EDUCATION

• UNIVERSITY OF WASHINGTON

  $10,000

  MENTORING PROGRAM

• WILLS EYE HOSPITAL

  $10,000

  MENTORING PROGRAM

• JOHNS HOPKINS UNIVERSITY

  $10,000

  MENTORING PROGRAM

• TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

  $10,000

  MENTORING PROGRAM

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

• AMERICAN GLAUCOMA SOCIETY FOUNDATION

  501(C)(3) · SUPPORT FOR GLAUCOMA RESEARCH AND EXCELLENCE IN GLAUCOMA TREATMENT · CA · controlled entity

  Directly controlled by AMERICAN GLAUCOMA SOCIETY

Provenance

Return type

form_990

Tax year

2024

Filed

13 August 2025

IRS schema version

2024v5.2

Source object

202522279349302632

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.